Results 91 to 100 of about 25,285 (271)
Bexarotene and Hypopituitarism
AACE Clinical Case Reports, 2015 ABSTRACT: Objective: Bexarotene is currently approved for treatment of cutaneous T-cell lymphoma and is also under investigation for other cancers such as lung, breast, and thyroid cancer. We recently reported a patient with mycosis fungoides treated with bexarotene.
Gülşen Işıklı +2 more
openaire +3 more sources
Biomarkers of Cellular Senescence in Type 2 Diabetes Mellitus
Aging Cell, Volume 24, Issue 8, August 2025.In cohorts of lean controls, obese participants without Type 2 Diabetes Mellitus (T2DM) and obese T2DM participants, we find that T‐cell expression of senescence biomarkers is altered only in the T2DM participants and not with obesity alone. Moreover, high T‐cell p16 expression in the T2DM participants is associated with impaired bone cortical indices.
Caroline Hoong +9 more
wiley +1 more source
Journal of the Pakistan Medical AssociationDear Editor, Hypopituitarism is a disorder characterized by insufficient hormone production from the pituitary gland,1,2 manifesting as either pan or partial dysfunction.2 Hypopituitarism is considered a rare disorder by National Institute of Health ...
Ayesha Imran Butt, Muhammad Juniad Azhar
doaj +1 more source
Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: is there a role for vitamin D? [PDF]
, 2015 Hypovitaminosis D represent an environmental risk factors for cardiovascular (CV) disease. To investigate the prevalence of hypovitaminosis D and the correlation between GH/IGF-I deficiency and hypovitaminosis D with CV risk in GH deficiency (GHD ...
BARREA, LUIGI +8 more
core +1 more source
Clinical Endocrinology, Volume 103, Issue 2, Page 216-224, August 2025.ABSTRACT Objective Patients require additional treatment when pituitary surgery for Cushing's disease is unsuccessful. Exciting innovations in pituitary surgery bring hope for achieving better outcomes. Quantifying the potential value of these innovations using early health economic modelling can provide guidance throughout their development.
Femke J. C. Jacobs +4 more
wiley +1 more source
Pituitary adenomas, some diagnostic and therapeutical aspects [PDF]
, 1994 The treatment of almost all types of pituitary adenomas has changed considerably in recent years. New types of drugs as well as improved application forms of older drug therapies are now becoming more and more available for everyday treatment of patients
Herder, W.W. (Wouter) de +2 more
core +1 more source
Pituitary dysfunction following traumatic brain injury: clinical perspectives
Neuropsychiatric Disease and Treatment, 2015 Fatih Tanriverdi, Fahrettin Kelestimur Department of Endocrinology, Erciyes University Medical School, Kayseri, Turkey Abstract: Traumatic brain injury (TBI) is a well recognized public health problem worldwide.
Tanriverdi F, Kelestimur F
doaj
Lymphocytic Hypophysitis [PDF]
, 2010 A 59 year-old female presented with visual problems in 2006, and was initially diagnosed with a pituitary macroadenoma on MRI (Figure 1). Preoperatively, the pituitary lesion decreased in size after the patient was started on steroids, raising the ...
Evans, James J. +4 more
core +2 more sources
Hormone replacement therapy in hypopituitarism [PDF]
, 2003 This article brings an updated review of hypopituitarism with emphasis in hormone replacement therapy. The physiological basis of hormone replacement therapy and practical aspects of treating hypopituitary patients were both taken into account to provide
Abucham, Julio +4 more
core +3 more sources